ijms-logo

Journal Browser

Journal Browser

Special Issue "Lipid as a Cancer Therapeutic Target 2.0"

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 30 September 2021.

Special Issue Editors

Prof. Dr. Elisabetta Albi
E-Mail Website
Guest Editor
Department of Pharmaceutical Science, University of Perugia, 06100 Perugia, Italy
Interests: lipid metabolism; nuclear lipids; cancer; cell proliferation and differentiation; neurodegenerative disorders; liver; brain; thyroid
Special Issues and Collections in MDPI journals
Prof. Dr. Andrea Huwiler
E-Mail Website
Co-Guest Editor
Institute of Pharmacology, University of Bern, Inselspital, CH-3010 Bern, Switzerland
Interests: sphingolipid signaling; prostaglandins; chronic inflammatory kidney diseases
Special Issues and Collections in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue is the continuation of our previous Special Issue “Lipid as a Cancer Therapeutic Target

Lipids are not only components of cellular membranes but also constitute important signaling molecules. They can influence cellular signaling pathways via binding to extracellular cellular receptors or intracellular molecules, such as phosphatases and kinases. Additionally, they can form special membrane domains, which represent important signaling platforms for the activation of membrane-associated proteins. With regard to these multiple cellular functions, lipids are important players in physiological and pathophysiological processes and interesting targets for mostly incurable diseases such as cancer. Prostaglandin E2 (PGE2) and sphingosine-1 phosphate (S1P) are well-known lipids that promote cancer growth. However, other lipids are also deregulated in cancer, and interfering with the synthesis or binding of these lipids is a promising approach for cancer therapy.

This Special Issue will summarize the current knowledge of therapeutics that target lipids as a new treatment option for cancer therapy. We invite researchers in the broad field of sphingolipids, cholesterol, prostaglandins, leukotrienes, and phospholipids to contribute to this Special Issue.

Prof. Dr. Elisabetta Albi
Guest Editor
Prof. Dr. Andrea Huwiler
Co-Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

This special issue is now open for submission.
Back to TopTop